Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102370195 | 10237019 | 5 | F | 2012 | 20160802 | 20140613 | 20160808 | EXP | US-BAYER-2014-052609 | BAYER | 69.00 | YR | E | M | Y | 0.00000 | 20160808 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102370195 | 10237019 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | UNK | N | 21923 | FILM-COATED TABLET | ||||||||
| 102370195 | 10237019 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID | N | AH006CR | 21923 | 400 | MG | FILM-COATED TABLET | BID | ||||
| 102370195 | 10237019 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 2 TABLETS DAILY | N | 21923 | 400 | MG | FILM-COATED TABLET | ||||||
| 102370195 | 10237019 | 4 | SS | NEXAVAR | SORAFENIB | 1 | 1 TABLET TWICE A DAY TO ALTERNATE WITH 1 TABLET IN THE MORNING AND 2 TABLETS IN THE EVENING | N | AH00TPA | 21923 | FILM-COATED TABLET | ||||||||
| 102370195 | 10237019 | 5 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 1 TABLET TWICE A DAY TO ALTERNATE WITH 1 TABLET IN THE MORNING AND 2 TABLETS IN THE EVENING | N | BXH4C75 | 21923 | FILM-COATED TABLET | |||||||
| 102370195 | 10237019 | 6 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 1 TABLET TWICE A DAY TO ALTERNATE WITH 1 TABLET IN THE MORNING AND 2 TABLETS IN THE EVENING | N | BXH5XH3 | 21923 | FILM-COATED TABLET | |||||||
| 102370195 | 10237019 | 7 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 9 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 10 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 11 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 12 | C | STROVITE | 2 | 0 | |||||||||||||
| 102370195 | 10237019 | 13 | C | CARTIA XT | DILTIAZEM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 14 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 15 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 16 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 17 | C | KOMBIGLYZE XR | METFORMIN HYDROCHLORIDESAXAGLIPTIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 102370195 | 10237019 | 18 | C | DIOVAN | VALSARTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102370195 | 10237019 | 1 | Thyroid cancer |
| 102370195 | 10237019 | 2 | Thyroid cancer |
| 102370195 | 10237019 | 3 | Thyroid cancer |
| 102370195 | 10237019 | 4 | Thyroid cancer |
| 102370195 | 10237019 | 5 | Thyroid cancer |
| 102370195 | 10237019 | 6 | Thyroid cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102370195 | 10237019 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102370195 | 10237019 | Abasia | |
| 102370195 | 10237019 | Acne | |
| 102370195 | 10237019 | Alopecia | |
| 102370195 | 10237019 | Blister | |
| 102370195 | 10237019 | Burning sensation | |
| 102370195 | 10237019 | Dry skin | |
| 102370195 | 10237019 | Impaired healing | |
| 102370195 | 10237019 | Off label use | |
| 102370195 | 10237019 | Pain in extremity | |
| 102370195 | 10237019 | Peripheral swelling | |
| 102370195 | 10237019 | Skin fissures | |
| 102370195 | 10237019 | Skin lesion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102370195 | 10237019 | 1 | 20120116 | 0 | ||
| 102370195 | 10237019 | 2 | 20120531 | 0 | ||
| 102370195 | 10237019 | 4 | 2012 | 0 |